Aug 07, 2019 / 12:00PM GMT
Operator
Good afternoon, ladies and gentlemen, and welcome to the Teva Pharmaceutical Industry's 2nd Quarter Financial results (Operator Instructions). I must advise you that this conference is being recorded today, Wednesday, August 7, 2019 and I would now like to hand the call over to your first speaker today, Kevin Mannix, Senior Vice President, Head of Investor Relations.
Kevin C. Mannix - Teva Pharmaceutical Industries Limited - SVP of IR
Good morning everyone, thanks for joining us today to discuss our 2nd Quarter 2019 financial results. We hope you've had an opportunity to review our earning press release. A copy of the release as well as a copy of the slides being presented on this call can be found on our website at www.tevapharm.com as well as through the Teva Investor Relations app.
Please note that the discussion on today's call includes certain non-GAAP measures that are defined by the SEC. Management uses both GAAP financial measures and the disclosed non-GAAP financial measures
Q2 2019 Teva Pharmaceutical Industries Ltd Earnings Call Transcript
Feb 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers